BMC cancer

BMC Cancer · ISSN (e) 1471-2407 · 141 papers in corpus
diagnostic-accuracy 2022
doi:10.1186/s12885-021-09073-z ·PMID:34980005

BACKGROUND: Circular RNAs (circRNAs) are more stable than linear RNA molecules, which makes them promising diagnostic biomarkers for diseases. By circRNA-sequencing analysis, we previously found that circN4BP2L2 was significantly decreased …

other 2022
doi:10.1186/s12885-022-10137-x ·PMID:36284282

BACKGROUND: This study observed and described the morphological characteristics of the endometrium of the resected uterus using confocal laser endomicroscopy. This included benign endometrium, non-atypical endometrial hyperplasia, atypical …

observational 2022
doi:10.1186/s12885-022-10179-1 ·PMID:36253767

BACKGROUND: Although there is broad consensus that only a subset of CIN3 will progress to cancer, there is currently no surefire way to predict which CIN3 will regress. Understanding the natural history of CIN3 is important, and finding mar…

observational 2022
doi:10.1186/s12885-022-10288-x ·PMID:36357914

BACKGROUND: Ureteral reconstruction is required after surgical resection of the tumor invading the urinary tract in ovarian cancer with low incidence. There are no currently reported surgical outcomes of ureteral reconstruction during cytor…

observational 2022
doi:10.1186/s12885-022-09588-z ·PMID:35461222

BACKGROUND: The aim of the present study was to assess the prevalence of deficient mismatch repair (MMR) in Chinese ovarian clear cell carcinoma (CCC) patients and its association with clinicopathologic features. METHODS: Immunohistochemis…

diagnostic-accuracy 2021
doi:10.1186/s12885-021-08682-y ·PMID:34530759

BACKGROUND: Trial on five plasma biomarkers (CA125, HE4, OPN, leptin, prolactin) and their possible role in differentiating benign from malignant ovarian tumors. METHODS: In this unicentric prospective trial preoperative blood samples of 4…

observational 2021
doi:10.1186/s12885-021-07869-7 ·PMID:33549065

BACKGROUND: The aim of this study was to assess the survival outcomes of cisplatin-paclitaxel chemotherapy plus bevacizumab (CPB) versus cisplatin-paclitaxel chemotherapy alone (CPA) in postmenopausal women with previously untreated advance…

observational 2021
doi:10.1186/s12885-021-08061-7 ·PMID:33766002

BACKGROUND: Ovarian clear cell carcinoma (OCCC) is a special pathological type of epithelial ovarian carcinoma (EOC). We conducted this research to investigate the clinical characteristics and outcomes of OCCC and to provide additional supp…

other 2021
doi:10.1186/s12885-021-08827-z ·PMID:34717566

BACKGROUND: Early recurrence is the major cause of poor prognosis in hepatocellular carcinoma (HCC). Long non-coding RNAs (lncRNAs) are deeply involved in HCC prognosis. In this study, we aimed to establish a prognostic lncRNA signature for…

meta-analysis 2021
doi:10.1186/s12885-021-08815-3 ·PMID:34615498

OBJECTIVE: To compare the value of fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT) and magnetic resonance imaging (MRI) in differentiating benign and malignant ovarian or adnexal tumors. MATERIALS AND MET…

meta-analysis 2020
doi:10.1186/s12885-020-07606-6 ·PMID:33228594

BACKGROUND: Research focusing on the relationship between five types of tumor necrosis factor-alpha (TNF-α) SNPs and the risk of hepatocellular carcinoma (HCC) were still controversial. Hereby, we performed a meta-analysis to determine the …

diagnostic-accuracy 2020
doi:10.1186/s12885-020-07468-y ·PMID:33059604

BACKGROUND: MCM5 is a protein involved in DNA replication, facilitating cell proliferation. In normal epithelium MCM5 expression is restricted to the cells in the basal proliferative compartments, however in the presence of a tumour MCM5 po…

observational 2020
doi:10.1186/s12885-020-07326-x ·PMID:32847533

BACKGROUND: Microwave ablation (MWA) is widely used to treat unresectable primary and secondary malignancies of the liver, and a limited number of studies indicate that ablation can cause not only necrosis at the in situ site but also an im…

meta-analysis 2020
doi:10.1186/s12885-020-6679-9 ·PMID:32164586

BACKGROUND: Existing data from several reports on the association between lipid profile and ovarian tumour (OT) suggests divergent conclusions. Our aim was to examine whether circulating lipid profile: total cholesterol (TC), triglyceride (…

observational 2020
doi:10.1186/s12885-020-6549-5 ·PMID:31996163

BACKGROUND: We previously reported that tamoxifen (TAM)-induced ovarian hyperstimulation (OHS) is associated with high serum concentrations of estradiol in premenopausal women with breast cancer. To investigate risk factors for TAM-induced …

diagnostic-accuracy 2020
doi:10.1186/s12885-020-6670-5 ·PMID:32178642

BACKGROUND: Considering the potential of p16 as a marker for diagnosis, prognosis and therapeutic response, the aim of this study was to assess its presence, via immunocytochemistry, in metastatic carcinoma of different primary sites and hi…

lab-animal 2020
doi:10.1186/s12885-020-07350-x ·PMID:32883230

BACKGROUND: Endometrial cancer, one of the most common malignant tumors, is a serious threat to women's health. Endometrial hyperplasia is a precursor of endometrial cancer. S100 calcium binding protein P (S100P) has been found to play impo…

lab-animal 2020
doi:10.1186/s12885-020-07455-3 ·PMID:33023525

BACKGROUND: Previous studies have shown a major green tea polyphenol (-)-epigallocatechin-3-gallate ((-)-EGCG) as a powerful anti-cancer agent. However, its poor bioavailability and requirement of a high dosage to manifest activity have res…

diagnostic-accuracy 2019
doi:10.1186/s12885-019-5556-x ·PMID:31035965

BACKGROUND: Endometrial cancer (EC) is the most common malignancy of the female reproductive tract. Despite years of research, the accurate screening strategy is still not available in this disease and it is usually diagnosed only after the…

other 2019
doi:10.1186/s12885-019-6339-0 ·PMID:31744494

BACKGROUND: High grade serous ovarian carcinoma (HGSOC) is the most common subtype of epithelial ovarian cancers (EOC) with poor prognosis. In most cases EOC is widely disseminated at the time of diagnosis. Despite the optimal cytoreductive…

case-report 2019
doi:10.1186/s12885-019-5934-4 ·PMID:31362708

BACKGROUND: Primary retroperitoneal serous adenocarcinoma (PRSA) is an extremely uncommon malignancy exclusively reported in females. Due to the rarity of the disease, it is difficult to establish a standardized treatment. CASE PRESENTATIO…

other 2019
doi:10.1186/s12885-019-6318-5 ·PMID:31718623

BACKGROUND: The aim of this study was to assess the agreement rate between intraoperative evaluation (IOE) and final diagnosis (FD) in a series of surgically resected endometrial carcinoma (EC), with a preoperative ambiguous or inconclusive…

observational 2019
doi:10.1186/s12885-019-6457-8 ·PMID:31888528

BACKGROUND: Testosterone implants have been used for over eighty years to treat symptoms of hormone deficiency in pre and postmenopausal women. Evidence supports that androgens are breast protective. However, there is a lack of data on the …

review 2019
doi:10.1186/s12885-019-6026-1 ·PMID:31409310

BACKGROUND: We report an extremely rare case of vaginal clear cell carcinoma, which originated from the malignant transformation of vaginal adenosis without prenatal diethylstilbestrol (DES) exposure. CASE PRESENTATION: In this case, the p…

case-report 2019
doi:10.1186/s12885-019-6272-2 ·PMID:31664961

BACKGROUND: Somatic PTEN mutation occurs in a proportion of ovarian endometrioid carcinomas. However, these cancers have seldom been reported in diseases associated with germline PTEN variants, such as Cowden syndrome (CS). CASE PRESENTATI…